Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study

American Heart Journal

Volumn 159, Issue 3, 2010, Pages 385-391

  Brown, Todd M ^a   Voeks, Jenifer H ^b   Bittner, Vera ^a   Safford, Monika M ^c  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CLASSIFICATION; FEMALE; GEOGRAPHY; HUMAN; ISCHEMIC HEART DISEASE; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; STROKE;

AFRICAN AMERICANS; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; CORONARY DISEASE; DEMOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE; UNITED STATES;

EID: 77649147159     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.022     Document Type: Article

References (41)

1. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US Adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
2. Gami A.S., Witt B.J., Howard D.E., et al. Metabolic syndrome and risk of incident cardiovascular events and death. J Am Coll Cardiol 49 (2007) 403-414
3. Echahidi N., Pibarot P., Despres J.P., et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 50 (2007) 843-851
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
5. Grundy S.M., Brewer H.B., Cleeman J.I., et al., For the Conference Participants. Definition of the Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 109 (2004) 433-438
6. The IDF consensus worldwide definition of the metabolic syndrome. Available at:. http://www.idf.org/webdata/docs/MetS_def_update2006.pdf Last accessed July 20, 2009
7. Ford E.S. Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation among adults in the US. Diabetes Care 28 (2005) 2745-2749
8. Rathmann W., Haastert B., Icks A., et al. Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: The KORA Survey 2000. Diabetes Care 29 (2006) 461
9. Lorenzo C., Serrano-Rios M., Martinez-Larrad M.T., et al. Geographic Variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 29 (2006) 685-691
10. Adams R.J., Appleton S., Wilson D.H., et al. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new international diabetes federation consensus definition. Diabetes Care 28 (2005) 2777-2779
11. Guerrero-Romero F., and Rodriguez-Moran M. Concordance Between the 2005 International Diabetes Federation Definition for Diagnosing Metabolic Syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization Definitions. Diabetes Care 28 (2005) 2588-2589
12. Bo S., Ciccone G., Pearce N., et al. Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects. Diabetes Research and Clinical Practice 75 (2007) 362-365
13. Gonzalez-Ortiz M., Martinez-Abundis E., Jacques-Camarena O., et al. Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the Adult Treatment Panel III criteria with the International Diabetes Federation definition. Acta Diabetol 43 (2006) 84-86
14. Katzmarzyk P.T., Janssen I., Ross R., et al. The importance of waist circumference in the definition of metabolic syndrome. Diabetes Care 29 (2006) 404-409
15. Lorenzo C., Williams K., Hunt K.J., et al. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30 (2007) 8-13
16. De Simone G., Devereux R.B., Chinali M., et al. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes. Diabetes Care 30 (2007) 1851-1856
17. Sandhofer A., Iglseder B., Paulweber B., et al. Comparison of different definitions of the metabolic syndrome. Eur J Clin Invest 37 (2007) 109-116
18. Skilton M.R., Moulin P., Serusclat A., et al. A comparison of the NCEP-ATPIII, IDF, and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis 190 (2007) 416-422
19. Nilsson P.M., Engstrom G., and Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects-a population-based study comparing three different definitions. Diabet Med 24 (2007) 464-472
20. Boulon C., Lafitte M., Richeboeuf V., et al. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance. Am J Cardiol 98 (2006) 1429-1434
21. Lawlor D.A., Smith G.D., and Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 49 (2006) 41-48
22. The DECODE study group, and Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 49 (2006) 2837-2846
23. Targher G., Bertolini L., Tessari R., et al. The International Diabetes Federation definition of the metabolic syndrome independently predicts future cardiovascular events in type 2 diabetic patients. The Valpolicella Heart Disease Study. Diabet Med 23 (2006) 1270-1271
24. Athyros V.G., Ganotakis E.S., Elisaf M.S., et al. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol 117 (2007) 204-210
25. Assmann G., Guerra R., Fox G., et al. Harmonizing the definition of the metabolic syndrome: Comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol 99 (2007) 541-548
26. Tong P.C., Kong A.P., So W.Y., et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 30 (2007) 1206-1211
27. Monami M., Marchionni N., Masotti G., et al. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type-2 diabetes patients. Diabetes Obes Metab 9 (2007) 350-353
28. Saely C.H., Koch L., Schmid F., et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 29 (2006) 901-907
29. Brown T.M., Vaidya D., Rogers W.J., et al. Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?. J Womens Health 17 (2008) 841-847
30. Wang J., Ruotsalainen S., Moilanen L., et al. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland. Stroke 39 (2008) 1078-1083
31. Howard V.J., Cushman M., Pulley L.V., et al. The REasons for Geographic And Racial Differences in Stroke (REGARDS) study: objectives and design. Neuroepidemiology 25 (2005) 135-143
32. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
33. Hu F.B., Stampfer M.J., Haffner S.M., et al. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25 (2002) 1129-1134
34. Coutinho M., Gerstein H.C., Wang Y., et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
35. Levitan E.B., Song Y., Ford E.S., et al. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Int Med 164 (2004) 2147-2155
36. Shubair M.M., Kodis J., McKelvie R.S., et al. Metabolic profile and exercise capacity outcomes. J Cardiopulm Rehabil 24 (2004) 405-413
37. Stewart K.J., Bacher A.C., Turner K., et al. Exercise and risk factors associated with metabolic syndrome in older adults. Am J Prev Med 28 (2005) 9-18
38. Katzmarzyk P.T., Leon A.S., Wilmore J.H., et al. Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. Med Sci Sports Exerc 35 (2003) 1703-1709
39. Grundy S.M., Hansen B., Smith S.C., et al., For Conference Participants. Clinical management of metabolic syndrome. Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on scientific issues related to management. Circulation 109 (2004) 551-556
40. Bassand J.P. Managing cardiovascular risk in patients with metabolic syndrome. Clinical Cornerstone 8 Suppl 1 (2006) S7-S14
41. D'Agostino R.B., Grundy S., Sullivan L.M., et al., For the CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187